Pig organs transplanted to monkeys, another new advance in cross-species transplantation
Release time:
2023-11-30
Multiple organs and tissues, including liver, kidney, heart, abdominal wall, cornea, bone, median nerve, etc., from a gene-edited pig were transplanted to seven recipient monkeys. "The study is another useful exploration and positive attempt to find out whether xenotransplantation of tissues and organs is feasible to be applied to emergency treatment of severe tissue destruction and organ failure, which will further expand the feasibility and effectiveness of confirming the application of xenotransplantation to medical rescue." At the media conference held on the 10th, Dou Kefeng, an academician of the Chinese Academy of Sciences, gave a high evaluation of the operation.
More than 40 specialists collaborated to perform seven surgeries
On November 10, the reporter learned from Xijing Hospital of Air Force Military Medical University that more than 20 disciplines of the hospital carried out multi-gene editing pig-monkey multi-organ and multi-tissue simultaneous transplantation surgery and then won a new breakthrough, in which the xenogeneic vascularization of the abdominal wall transplantation by searching the domestic and foreign literature has not been reported, is still the first case.
According to the World Health Organization, there is a serious shortage of human organs available for transplantation, and at present, about 2 million people around the world are in need of organ transplants every year. in 2021, the number of organ transplants worldwide will reach 144,300, but only about 10% of the patients will have to wait for a suitable organ. Currently, international and domestic allogeneic organ and tissue transplants using gene-edited pigs as donors are moving toward preclinical trials.
Preparations for this surgery began in April 2023 and progressed according to several stages, including ethical justification, donor-recipient matching, surgical program determination, and pre-trial implementation. The series of transplantation surgeries was carried out from October 29 to 30, led by Academician Dou Kefeng, with the collaboration of more than 40 experts in hepatobiliary, pancreatic and splenic surgery, plastic surgery, urology, cardiovascular surgery, anesthesiology, orthopedics, ophthalmology and neurosurgery, to transplant several organs and tissues, including liver, kidney, heart, abdominal wall, cornea, bone, median nerve, etc., from a gene-edited pig to seven recipient monkeys.
Specialists in neurosurgery and orthopedics performed bone grafting and median nerve grafting, respectively. (Photo by the interviewed organization)
Accumulating important supportive basis for xenogeneic organ transplantation towards the clinic
After the blood flow of the transplanted organ is restored, bile can be seen flowing out of the transplanted liver immediately; the transplanted kidney produces urine immediately; the transplanted heart resumes beating regularly and vigorously. The liver, kidney and heart functioned well after the operation.
The 32cm×12cm transplanted abdominal wall was made of "skin, fat, muscle, peritoneum, ribs and rib cartilage and other composite tissues", which overcame the problem of the difference in the diameter of blood vessels between the donor and the recipient during the operation, as well as the difficulty of bleeding from postoperative gastrointestinal tract stress ulcers, and the difficulty of early immune rejection, and has been survived well so far. The transplanted corneal grafts and graft beds are transparent, and the postoperative indicators are significantly better than those of the control group. Synchronized bone transplantation and median nerve transplantation, to be assessed after 3 months of fusion and function of the transplanted bone.
Liu Jincheng, director of cardiovascular surgery at Xijing Hospital, told reporters that previous transplants were abdominal ectopic heart transplants, removing the pig's heart and transplanting it in the monkey's abdominal cavity, with the monkey's own heart still preserved, and the main observation of the rejection of pig-monkey xenotransplantation of heart transplantation; this surgery was an in situ heart transplantation, replacing the monkey's heart with the heart of the pig completely. Since both the donor and recipient animals were very small, and the heart was only the size of a walnut, the operation was very difficult, but the whole operation went very smoothly, and the monkey recovered its heartbeat in more than 40 minutes after the operation, and was taken off the ventilator the next day, with its vital signs stabilized. The success and breakthrough of xenotransplantation over and over again has accumulated valuable experience towards the clinic, and in the future, it is expected to realize the use of pig organs instead of human organs to save the lives of human beings.
Longest Case! Survival of over two years after cross-species transplantation
In the past two years, there have been special cases of transplanting pig hearts or kidneys into brain-dead and critically ill patients. Recently, Nature announced a "milestone" achievement, with the help of CRISPR-Cas9 gene editing technology, researchers at the University of Cambridge have created the longest case of cross-species transplantation survival to date! This is a huge step forward in the feasibility of xenotransplantation!
The paper, titled "Design and testing of a humanized porcine donor for xenotransplantation," states that scientists have successfully transplanted a porcine kidney with 69 gene edits across species into the body of a crab-eating monkey. The article states that scientists have successfully transplanted a 69-part gene-edited porcine kidney across species into the body of a crab-eating monkey, and have achieved an extraordinarily long survival time of 758 days, surpassing the two-year mark, which undoubtedly gives everyone a shot of "strong medicine".
Making pig organs "work" in monkeys, a close relative of humans, is a major leap forward in medicine, with a series of excellent data proving that gene-edited pig organs can survive in xenografts. At the same time, the researchers designed the pig genome with humans in mind, rather than non-human primates, so they may perform better in humans.
Previous article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
